Arginine vasopressin levels after daily infusions of antisense oligonucleotides into the supraoptic nucleus.
Flanagan
L M
LM
Laboratory of Neuroendocrinology, Rockefeller University, New York, New York 10021.
McCarthy
M M
MM
Brooks
P J
PJ
Pfaff
D W
DW
McEwen
B S
BS
D000818:Animals; D001127:Arginine Vasopressin / Q000037:antagonists & inhibitors* / Q000378:metabolism; D004334:Drug Administration Schedule; D007267:Injections; D016376:Oligonucleotides, Antisense / Q000008:administration & dosage / Q000494:pharmacology*; D009994:Osmolar Concentration; D010121:Oxytocin / Q000378:metabolism; D010286:Paraventricular Hypothalamic Nucleus / Q000378:metabolism; D010902:Pituitary Gland / Q000378:metabolism; D051381:Rats; D013495:Supraoptic Nucleus / Q000378:metabolism*; D014556:Urine / Q000737:chemistry
D016376:Oligonucleotides, Antisense; D001127:Arginine Vasopressin; D010121:Oxytocin